Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerAI sign LanguageOpen
VIPCreated with Sketch.

Optimized dithranol-imiquimod-based transcutaneous immunization enables tumor rejection.

Ann-Kathrin Hartmann,Joschka Bartneck,Jonas Pielenhofer,Sophie Luise Meiser,Danielle Arnold-Schild,Matthias Klein,Michael Stassen,Hansjörg Schild,Sabine Muth,Hans Christian Probst,Peter Langguth,Stephan Grabbe,Markus P Radsak

Frontiers in immunology（2023）

Cited 0|Views9
No score
Abstract
Taken together, the described optimized transcutaneous vaccination method leads to the generation of a strong cellular immune response enabling the effective control of tumor growth and has the potential for clinical development as a novel non-invasive vaccination method for peptide-based cancer vaccines in humans.
More
Translated text
Key words
transcutaneous immunization,tumor rejection,dithranol-imiquimod-based
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined